Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Metformin shows knee OA pain-relieving potential
Metformin shows knee OA pain-relieving potential
03 May 2025 bởiJairia Dela Cruz

Metformin, a common medication for diabetes, appears to produce a moderate reduction in knee pain and stiffness for overweight or obese individuals with symptomatic knee osteoarthritis (OA), as shown in the results of a randomized clinical trial.

Metformin shows knee OA pain-relieving potential
03 May 2025
LHRH analogues vs tE2 patches: Which work best for prostate cancer?
LHRH analogues vs tE2 patches: Which work best for prostate cancer?
02 May 2025
SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?
SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?
30 Apr 2025 bởiStephen Padilla

In patients with treatment-naive metastatic nonsmall cell lung cancer (NSCLC), subcutaneous (SC) pembrolizumab (pembro) demonstrates comparable efficacy to that of intravenous (IV) pembro as regards overall exposure and trough concentration, reports a study presented at ELCC 2025.

SC vs IV pembrolizumab: Which route is better for metastatic NSCLC?
30 Apr 2025